Association between the DAOA/G72 gene and bipolar disorder and meta-analyses in bipolar disorder and schizophrenia

Bipolar Disorders

Volumn 13, Issue 2, 2011, Pages 198-207

  Müller, Daniel J ^a   Zai, Clement C ^a   Shinkai, Takahiro ^b   Strauss, John ^a   Kennedy, James L ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Bipolar disorder; d amino acid oxidase activator (DAOA G72); Family based association test; Genetics; Meta analysis; Schizophrenia

Indexed keywords

ADULT; ARTICLE; BIPOLAR DISORDER; DAOA GENE; ETHNIC DIFFERENCE; EUROPE; FEMALE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATION; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SOUTHEAST ASIA;

ADULT; BIPOLAR DISORDER; CARRIER PROTEINS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; META-ANALYSIS AS TOPIC; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA;

EID: 79953039755     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2011.00905.x     Document Type: Article

References (49)

1. Craddock N, O'Donovan MC, Owen MJ. Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr Bull 2006; 32: 9-16.
2. Malhi GS, Green M, Fagiolini A, Peselow ED, Kumari V. Schizoaffective disorder: diagnostic issues and future recommendations. Bipolar Disord 2008; 10: 215-230.
3. Lichtenstein P, Yip BH, Björk C et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009; 373: 234-239.
4. Badner JA, Gershon ES. Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry 2002; 7: 405-411.
5. Lewis CM, Levinson DF, Wise LH et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: schizophrenia. Am J Hum Genet 2003; 73: 34-48.
6. Chumakov I, Blumenfeld M, Guerassimenko O et al. Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci USA 2002; 99: 13675-13680.
7. Sacchi S, Bernasconi M, Martineau M et al. pLG72 modulates intracellular D-serine levels through its interaction with D-amino acid oxidase: effect on schizophrenia susceptibility. J Biol Chem 2008; 283: 22244-22256.
8. Boks MP, Rietkerk T, van de Beek MH, Sommer IE, de Koning TJ, Kahn RS. Reviewing the role of the genes G72 and DAAO in glutamate neurotransmission in schizophrenia. Eur Neuropsychopharmacol 2007; 17: 567-572.
9. Kvajo M, Dhilla A, Swor DE, Karayiorgou M, Gogos JA. Evidence implicating the candidate schizophrenia/bipolar disorder susceptibility gene G72 in mitochondrial function. Mol Psychiatry 2008; 13: 685-696.
10. Otte DM, Bilkei-Gorzó A, Filiou MD et al. Behavioral changes in G72/G30 transgenic mice. Eur Neuropsychopharmacol 2009; 19: 339-348.
11. Fallin MD, Lasseter VK, Avramopoulos D et al. Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am J Hum Genet 2005; 77: 918-936.
12. Shi J, Badner JA, Gershon ES, Liu C. Allelic association of G72/G30 with schizophrenia and bipolar disorder: a comprehensive meta-analysis. Schizophr Res 2008; 98: 89-97.
13. Hattori E, Liu C, Badner JA et al. Polymorphisms at the G72/G30 gene locus, on 13q33, are associated with bipolar disorder in two independent pedigree series. Am J Hum Genet 2003; 72: 1131-1140.
14. Chen YS, Akula N, Detera-Wadleigh SD et al. Findings in an independent sample support an association between bipolar affective disorder and the G72/G30 locus on chromosome 13q33. Mol Psychiatry 2004; 9: 87-92.
15. Schumacher J, Jamra RA, Freudenberg J et al. Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder. Mol Psychiatry 2004; 9: 203-207.
16. Williams NM, Green EK, Macgregor S et al. Variation at the DAOA/G30 locus influences susceptibility to major mood episodes but not psychosis in schizophrenia and bipolar disorder. Arch Gen Psychiatry 2006; 63: 366-373.
17. Prata D, Breen G, Osborne S, Munro J, St Clair D, Collier D. Association of DAO and G72(DAOA)/G30 genes with bipolar affective disorder. Am J Med Genet B Neuropsychiatr Genet 2008; 147B: 914-917.
18. Schulze TG, Ohlraun S, Czerski PM et al. Genotype-phenotype studies in bipolar disorder showing association between the DAOA/G30 locus and persecutory delusions: a first step toward a molecular genetic classification of psychiatric phenotypes. Am J Psychiatry 2005; 162: 2101-2108.
19. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID I). New York: Biometrics Research, New York State Psychiatric Institute, 1997.
20. Carter TD, Mundo E, Parikh SV, Kennedy JL. Early age at onset as a risk factor for poor outcome of bipolar disorder. J Psychiatr Res 2003; 37: 297-303.
21. Gauderman WJ, Morrison JM. QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies. Last accessed 14 February 2011.
22. Horvath S, Xu X, Laird NM. The family based association test method: strategies for studying general genotype-phenotype associations. Eur J Hum Genet 2001; 9: 301-306.
23. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.
24. Nyholt DR. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 2004; 74: 765-769.
25. Nicodemus KK. Catmap: case-control and TDT meta-analysis package. BMC Bioinformatics 2008; 9: 130.
26. Zai CC, Tiwari AK, Müller DJ et al. The catechol-O-methyl-transferase gene in tardive dyskinesia. World J Biol Psychiatry 2010; 11: 803-812.
27. Bakker SC, Hoogendoorn ML, Hendriks J et al. The PIP5K2A and RGS4 genes are differentially associated with deficit and non-deficit schizophrenia. Genes Brain Behav 2007; 6: 113-119.
28. Maheshwari M, Shi J, Badner JA et al. Common and rare variants of DAOA in bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 2009; 150B: 960-966.
29. Zuliani R, Moorhead TW, Job D et al. Genetic variation in the G72 (DAOA) gene affects temporal lobe and amygdala structure in subjects affected by bipolar disorder. Bipolar Disord 2009; 11: 621-627.
30. Yatham LN. Translating knowledge of genetics and pharmacology into improving everyday practice. Bipolar Disord 2005; 7 (Suppl. 4): 13-20.
31. Bass NJ, Datta SR, McQuillin A et al. Evidence for the association of the DAOA (G72) gene with schizophrenia and bipolar disorder but not for the association of the DAO gene with schizophrenia. Behav Brain Funct 2009; 5: 28.
32. Grigoroiu-Serbanescu M, Herms S, Diaconu CC et al. Possible association of different G72/G30 SNPs with mood episodes and persecutory delusions in bipolar I Romanian patients. Prog Neuropsychopharmacol Biol Psychiatry 2010; 34: 657-663.
33. Gaysina D, Cohen-Woods S, Chow PC et al. Association analysis of DAOA and DAO in bipolar disorder: results from two independent case-control studies. Bipolar Disord 2010; 12: 579-581.
34. Addington AM, Gornick M, Sporn AL et al. Polymorphisms in the 13q33.2 gene G72/G30 are associated with childhood-onset schizophrenia and psychosis not otherwise specified. Biol Psychiatry 2004; 55: 976-980.
35. Korostishevsky M, Kaganovich M, Cholostoy A et al. Is the G72/G30 locus associated with schizophrenia? single nucleotide polymorphisms, haplotypes, and gene expression analysis. Biol Psychiatry 2004; 56: 169-176.
36. Wang X, He G, Gu N et al. Association of G72/G30 with schizophrenia in the Chinese population. Biochem Biophys Res Commun 2004; 319: 1281-1286.
37. Mulle JG, Chowdari KV, Nimgaonkar V, Chakravarti A. No evidence for association to the G72/G30 locus in an independent sample of schizophrenia families. Mol Psychiatry 2005; 10: 431-433.
38. Zou F, Li C, Duan S et al. A family-based study of the association between the G72/G30 genes and schizophrenia in the Chinese population. Schizophr Res 2005; 73: 257-261.
39. Hong CJ, Hou SJ, Yen FC, Liou YJ, Tsai SJ. Family-based association study between G72/G30 genetic polymorphism and schizophrenia. Neuroreport 2006; 17: 1067-1069.
40. Ma J, Qin W, Wang XY et al. Further evidence for the association between G72/G30 genes and schizophrenia in two ethnically distinct populations. Mol Psychiatry 2006; 11: 479-487.
41. Corvin A, McGhee KA, Murphy K et al. Evidence for association and epistasis at the DAOA/G30 and D-amino acid oxidase loci in an Irish schizophrenia sample. Am J Med Genet B Neuropsychiatr Genet 2007; 144B: 949-953.
42. Shin HD, Park BL, Kim EM et al. Association analysis of G72/G30 polymorphisms with schizophrenia in the Korean population. Schizophr Res 2007; 96: 119-124.
43. Shinkai T, De Luca V, Hwang R et al. Association analyses of the DAOA/G30 and D-amino-acid oxidase genes in schizophrenia: further evidence for a role in schizophrenia. Neuromolecular Med 2007; 9: 169-177.
44. Yue W, Kang G, Zhang Y et al. Association of DAOA polymorphisms with schizophrenia and clinical symptoms or therapeutic effects. Neurosci Lett 2007; 416: 96-100.
45. Sanders AR, Duan J, Levinson DF et al. No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. Am J Psychiatry 2008; 165: 497-506.
46. Vilella E, Costas J, Sanjuan J et al. Association of schizophrenia with DTNBP1 but not with DAO, DAOA, NRG1 and RGS4 nor their genetic interaction. J Psychiatr Res 2008; 42: 278-288.
47. Jönsson EG, Saetre P, Vares M et al. DTNBP1, NRG1, DAOA, DAO and GRM3 polymorphisms and schizophrenia: an association study. Neuropsychobiology 2009; 59: 142-150.
48. Ohi K, Hashimoto R, Yasuda Y et al. Association study of the G72 gene with schizophrenia in a Japanese population: a multicenter study. Schizophr Res 2009; 109: 80-85.
49. Réthelyi JM, Bakker SC, Polgár P et al. Association study of NRG1, DTNBP1, RGS4, G72/G30, and PIP5K2A with schizophrenia and symptom severity in a Hungarian sample. Am J Med Genet B Neuropsychiatr Genet 2010; 153B: 792-801.